Rhythm Pharmaceuticals (FRA:1RV) Accumulated Depreciation : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Rhythm Pharmaceuticals's quarterly accumulated depreciation increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-3.72 Mil) but then stayed the same from Dec. 2023 (€-3.72 Mil) to Mar. 2024 (€0.00 Mil).

Rhythm Pharmaceuticals's annual accumulated depreciation increased from Dec. 2021 (€-2.00 Mil) to Dec. 2022 (€-2.98 Mil) and increased from Dec. 2022 (€-2.98 Mil) to Dec. 2023 (€-3.72 Mil).

Rhythm Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Rhythm Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Accumulated Depreciation Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.68

-1.19

-2.00

-2.98

-3.72

Rhythm Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-3.72	-

Rhythm Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Rhythm Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals (FRA:1RV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

RYTM:USA RYTM:Mexico 1RV:Germany

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (FRA:1RV) Headlines

No Headlines